Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant IL-6R (Tocilizumab Biosimilar) antibody

The Humanized Monoclonal anti-IL-6R (Tocilizumab Biosimilar) antibody has been validated for FACS and in vivo. It is suitable to detect IL-6R (Tocilizumab Biosimilar) in samples from Human.
Catalog No. ABIN7795095

Quick Overview for Recombinant IL-6R (Tocilizumab Biosimilar) antibody (ABIN7795095)

Target

IL-6R (Tocilizumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
  • 1
  • 1
  • 1
Humanized

Clonality

  • 4
  • 2
Monoclonal

Conjugate

  • 5
  • 1
This IL-6R (Tocilizumab Biosimilar) antibody is un-conjugated

Application

  • 5
  • 2
  • 2
Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody

    Characteristics

    What is tocilizumab biosimilar research grade? Tocilizumab biosimilar uses the same protein sequences as the therapeutic antibody tocilizumab. Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. Interleukin 6 (IL-6) is a pro-inflammatory cytokine produced by cells including T-cells, B-cells, lymphocytes, monocytes, fibroblasts. IL-6 rapidly induces C-reactive protein, serum amyloid A, fibrinogen, haptoglobin, and α-1-antichymotrypsin while inhibiting production of fibronectin, albumin, and transferrin. IL-6 also induces antibody production, induces cytotoxic T-cell differentiation, and inhibits regulatory T-cell differentiation. Tocilizumab binds soluble and membrane bound IL-6 receptors, preventing IL-6 mediated inflammation.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Endotoxin Level

    < 1 EU per 1 mg of the protein by the LAL method

    Immunogen

    Human IL-6R
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    IL-6R (Tocilizumab Biosimilar)

    Alternative Name

    Tocilizumab Biosimilar

    Target Type

    Biosimilar
You are here:
Chat with us!